China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 7.40 billion. The enterprise value is 4.14 billion.
| Market Cap | 7.40B |
| Enterprise Value | 4.14B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | Oct 13, 2025 |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | -3.91% |
| Owned by Insiders (%) | 6.50% |
| Owned by Institutions (%) | 5.46% |
| Float | 204.29M |
Valuation Ratios
The trailing PE ratio is 17.58.
| PE Ratio | 17.58 |
| Forward PE | n/a |
| PS Ratio | 2.15 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | 18.43 |
| P/OCF Ratio | 15.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.17, with an EV/FCF ratio of 10.31.
| EV / Earnings | 9.83 |
| EV / Sales | 1.20 |
| EV / EBITDA | 7.17 |
| EV / EBIT | 11.00 |
| EV / FCF | 10.31 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.99% and return on invested capital (ROIC) is 11.17%.
| Return on Equity (ROE) | 6.99% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.17% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.01% |
| Revenue Per Employee | 1.04M |
| Profits Per Employee | 127,574 |
| Employee Count | 3,302 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:603367 has paid 70.58 million in taxes.
| Income Tax | 70.58M |
| Effective Tax Rate | 14.22% |
Stock Price Statistics
The stock price has increased by +26.74% in the last 52 weeks. The beta is 0.33, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +26.74% |
| 50-Day Moving Average | 17.15 |
| 200-Day Moving Average | 19.94 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 8,493,904 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.44 billion and earned 421.25 million in profits. Earnings per share was 0.93.
| Revenue | 3.44B |
| Gross Profit | 1.79B |
| Operating Income | 376.64M |
| Pretax Income | 496.19M |
| Net Income | 421.25M |
| EBITDA | 575.73M |
| EBIT | 376.64M |
| Earnings Per Share (EPS) | 0.93 |
Balance Sheet
The company has 3.34 billion in cash and 43.06 million in debt, with a net cash position of 3.30 billion or 7.29 per share.
| Cash & Cash Equivalents | 3.34B |
| Total Debt | 43.06M |
| Net Cash | 3.30B |
| Net Cash Per Share | 7.29 |
| Equity (Book Value) | 6.19B |
| Book Value Per Share | 13.59 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 466.37 million and capital expenditures -64.76 million, giving a free cash flow of 401.61 million.
| Operating Cash Flow | 466.37M |
| Capital Expenditures | -64.76M |
| Depreciation & Amortization | 199.09M |
| Net Borrowing | -55.46M |
| Free Cash Flow | 401.61M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 51.89%, with operating and profit margins of 10.93% and 12.23%.
| Gross Margin | 51.89% |
| Operating Margin | 10.93% |
| Pretax Margin | 14.40% |
| Profit Margin | 12.23% |
| EBITDA Margin | 16.71% |
| EBIT Margin | 10.93% |
| FCF Margin | 11.66% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 2.30%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 2.30% |
| Dividend Growth (YoY) | -37.80% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.42% |
| Buyback Yield | 0.31% |
| Shareholder Yield | 2.61% |
| Earnings Yield | 5.69% |
| FCF Yield | 5.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |